Effect of Glucagon-Like Peptide-1 (GLP-1) on Glycemic Control and Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting-Reference-Cited by-同舟云学术

Effect of Glucagon-Like Peptide-1 (GLP-1) on Glycemic Control and Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting

Published:2007-09 Issue:5 Volume:100 Page:824-829
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Sokos George G.,Bolukoglu Hakki,German Judy,Hentosz Teresa,Magovern George J.,Maher Thomas D.,Dean David A.,Bailey Stephen H.,Marrone Gary,Benckart Daniel H.,Elahi Dariush,Shannon Richard P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans;Flint;J Clin Invest,1998

2. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects;Elahi;Regul Pept,1994

3. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans;Meier;Am J Physiol Endocrinol Metab,2006

4. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion;Nikolaidis;Circulation,2004

5. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure;Sokos;J Card Fail,2006

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis;Perioperative Medicine;2024-07-22

2. Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice;Anaesthesia;2024-05-13

3. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A_2AR improves hepatic and cardiac dysfunction of NASH mice;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-04-01

4. Glucagon-like Peptide-1 Agonists;JBJS Reviews;2024-01

5. Possible Mechanisms and Molecular Signaling of Incretins against the Development of Type 2 Diabetes Mellitus;Current Molecular Pharmacology;2023-06